Hepatitis C is an unrecognized health crisis in the United States. This life-threatening infection affects an estimated 5.2 million Americans, most of whom are "baby boomers" (those born from 1945-1965). And while newly available treatments can cure the majority of persons treated for hepatitis C, most people are unaware of their infection.
Diagnosing hepatitis C early is key, since the longer the virus goes undetected, the greater the person's risk of transmission and of developing serious liver disease, including liver cancer and cirrhosis. Deaths due to hepatitis C are increasing, reaching more than 15,000 in 2007.
CDC has expanded their recommendations for testing to support one time testing to all baby boomers (born between 1945 and 1965) and the USPSTF recommends screening for hepatitis C virus (HCV) infection in persons at high risk for infection. The USPSTF also recommends offering one-time screening for HCV infection to all baby boomers. OraQuick Rapid HCV can provide a lab accurate antibody result in 20 minutes while you are in your doctor's office. In one office visit, you can get your antibody test result, linkage to follow up testing and linked to care.
There is a test that delivers accurate results in 20 minutes with just a finger stick drop of blood. Introducing the first and only FDA-approved, CLIA-waived rapid HCV Antibody Test.
The OraQuick HCV Rapid Antibody Test enables healthcare providers to deliver a lab accurate test result and at-risk patients the ability to take the next steps in linkage to care and treatment.